IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?
IHE's top two holdings account for over 43% of its portfolio, while IXJ spreads risk across 110 international stocks. Which concentration strategy fits your risk tolerance?
Overview
Investors comparing the iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) and the iShares Global Healthcare ETF (NYSEMKT:IXJ) must choose between concentrated U.S. pharmaceutical industry exposure and a broader, global healthcare strategy.
Both funds offer targeted access to the healthcare sector, yet they take fundamentally different geographic and industry approaches. While IHE focuses exclusively on the domestic drug manufacturing and distribution pipeline, IXJ captures a wider array of global companies, including medical device makers, biotechnology firms, and healthcare services across international markets.
Details
The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Source
Originally published at www.fool.com.
Related Articles
- The White House Is Renewing Its Push for a Strategic Bitcoin Reserve. Here's What That Could Mean for Bitcoin.
- Mark Zuckerberg's Meta and Other Hyperscalers Face a Major Bottleneck. Here Are 2 Industrial Stocks That Will Benefit
- Chubb Trades at Just 12 Times Earnings, Well Below the Broader Market. Is One of the World's Biggest Insurers a Bargain?